In Print
Photo by Graham Ramsay
From Focus:
Familiar
Antibiotic Slows Prostate Cancer Growth
Chemotherapy has been the least well-developed approach in the fight against
prostate cancer. Part of the problem has been the lack of a good target. Norie
Yoshioka (right), Guo-fu Hu, and colleagues report that they have discovered
such a target—angiogenin. They have also identified a drug, the old-line
antibiotic neomycin, that effectively blocks it.
Upcoming
Harvard University Program in Ethics and Health
Facing Paternalism in Research
Ethics
Monday, Oct. 16
4–6 pm
|
|
Spotlight
Dean
Joseph Martin Announces Plans to Step Down
Dean Joseph Martin announced that he will step down as dean of
HMS next July, after completing ten years of leadership and guiding
the School toward increased collaboration in research and education.
Student Scene
Photo by Patrick Ladapo
Diversity Strategies Change,
Goal Remains to Improve Patient Care
Joe Ladapo reports on the diversity efforts at HMS since the 1970s
and the national context for efforts to close health disparities.
Lab Works
A multimedia site featuring Harvard
Medical research.
StudenTalk
Personal takes on issues inside and
outside the classroom.
|
